IL-17 genetic and immunophenotypic evaluation in chronic graft-versus-host disease

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Resende, Renata Gonçalves ^a   Correia Silva, Jeane De Fátima ^b   Silva, Tarcília Aparecida ^c   Salomão, Ulisses Eliezer ^c   Marques Silva, Luciano ^d   Vieira, Érica Leandro Marciano ^c   Dutra, Walderez Ornelas ^c   Gomez, Ricardo Santiago ^c  

^a Hospital Municipal Odilon Behrens   (Brazil)

^b CENTRO UNIVERSITÁRIO NEWTON PAIVA   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^d Ciodonto Universidade FACSETE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; CD2 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CYCLOSPORIN; INTERLEUKIN 17; INTERLEUKIN 17F; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLATE MOFETIL;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CD4+ T LYMPHOCYTE; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GRAFT RECIPIENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; OUTCOME ASSESSMENT; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SALIVA LEVEL; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; GRAFT VERSUS HOST REACTION; MIDDLE AGED; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENOTYPE; GRAFT VS HOST DISEASE; HUMANS; INTERLEUKIN-17; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; YOUNG ADULT;

EID: 84927172720     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/571231     Document Type: Article

References (28)

1. B. E. Anderson, J. M. McNiff, D. Jain, B. R. Blazar, W. D. Shlomchik, and M. J. Shlomchik, "Distinct roles for donorand host-derived antigen-presenting cells and costimulatory molecules inmurine chronic graft-versus-host disease: requirements depend on target organ, " Blood, vol. 105, no. 5, pp. 2227-2234, 2005.
2. M. R. van den Brink and S. J. Burakoff, "Cytolytic pathways in haematopoietic stem-cell transplantation, " Nature Reviews Immunology, vol. 2, no. 4, pp. 273-281, 2002.
3. M. C. Pasquini, L. M. Griffith, D. L. Arnold et al. , "Hematopoietic stem cell transplantation for multiple sclerosis: collaboration of the CIBMTR and EBMT to facilitate international clinical studies, " Biology of Blood and Marrow Transplantation, vol. 16, no. 8, pp. 1076-1083, 2010.
4. B. R. Blazar, W. J. Murphy, and M. Abedi, "Advances in graft-versus-host disease biology and therapy, " Nature Reviews Immunology, vol. 12, no. 6, pp. 443-458, 2012.
5. K. J. Wood, A. Bushell, and J. Hester, "Regulatory immune cells in transplantation, " Nature Reviews Immunology, vol. 12, no. 6, pp. 417-430, 2012.
6. J. S. Serody and G. R. Hill, "The IL-17 differentiation pathway and its role in transplant outcome, " Biology of Blood andMarrow Transplantation, vol. 18, no. 1, pp. S56-S61, 2012.
7. L. E. Harrington, R. D. Hatton, P. R. Mangan et al. , "Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages, " Nature Immunology, vol. 6, no. 11, pp. 1123-1132, 2005.
8. Z. Yao, W. C. Fanslow, M. F. Seldin et al. , "Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor, " Immunity, vol. 3, no. 6, pp. 811-821, 1995.
9. H. Park, Z. Li, X. O. Yang et al. , "A distinct lineage of CD4 T cells regulates tissue in?ammation by producing interleukin 17, " Nature Immunology, vol. 6, no. 11, pp. 1133-1141, 2005.
10. K. Shibata, H. Yamada, R. Nakamura, X. Sun, M. Itsumi, and Y. Yoshikai, "Identification of CD25+ γ T cells as fetal thymusderived naturally occurring IL-17 producers, " The Journal of Immunology, vol. 181, no. 9, pp. 5940-5947, 2008.
11. J. D. Correa, M. F. M. Madeira, R. G. Resende et al. , "Association between polymorphisms in interleukin-17A and -17F genes and chronic periodontal disease, " Mediators of Inflammation, vol. 2012, Article ID846052, 9 pages, 2012.
12. J. L. Espinoza, A. Takami, M. Onizuka et al. , "Asingle nucleotide polymorphism of IL-17 gene in the recipient is associated with acute GVHD after HLA-matched unrelated BMT, " Bone Marrow Transplantation, vol. 46, no. 11, pp. 1455-1463, 2011.
13. A. H. Filipovich, D. Weisdorf, S. Pavletic et al. , "National Institutes of Health consensus development project on criteria for clinical trials in chronic graft -versus-host disease: I. diagnosis and staging working group report, " Biology of Blood andMarrow Transplantation, vol. 11, no. 12, pp. 945-956, 2005.
14. X. Wu, Z. Zeng, B. Chen et al. , "Association between polymorphisms in interleukin-17A and interleukin-17F genes and risks of gastric cancer, " International Journal of Cancer, vol. 127, no. 1, pp. 86-92, 2010.
15. M. Kawaguchi, D. Takahashi, N. Hizawa et al. , "IL-17F sequence variant (His161Arg) is associated with protection against asthma and antagonizes wild-type IL-17F activity, " Journal of Allergy and Clinical Immunology, vol. 117, no. 4, pp. 795-801, 2006.
16. M. J. Carlson, M. L. West, J. M. Coghill, A. Panoskaltsis-Mortari, B. R. Blazar, and J. S. Serody, "In vitro differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations, " Blood, vol. 113, no. 6, pp. 1365-1374, 2009.
17. C. Iclozan, Y. Yu, C. Liu et al. , "T helper17 cells are sufficient but not necessary to induce acute graft-versus-host disease, " Biology of Blood andMarrow Transplantation, vol. 16, no. 2, pp. 170-178, 2010.
18. T. Yi, D. Zhao, C. Lin et al. , "Absence of donor Thl7 leads to augmented Thl differentiation and exacerbated acute graftversus-host disease, " Blood, vol. 112, no. 5, pp. 2101-2110, 2008.
19. T. Arisawa, T. Tahara, T. Shibata et al. , "The influence of polymorphisms of interleukin-17A and interleukin-17F genes on the susceptibility to ulcerative colitis, " Journal of Clinical Immunology, vol. 28, no. 1, pp. 44-49, 2008.
20. G. B. N. Nordang, M. K. Viken, J. E. Hollis-moffatt et al. , "Association analysis of the interleukin 17A gene in Caucasian rheumatoid arthritis patients from Norway and New Zealand, " Rheumatology, vol. 48, no. 4, pp. 367-370, 2009.
21. W. C. Jang, Y. H. Nam, Y. C. Ahn et al. , "Interleukin-17F gene polymorphisms in Korean patients with Behcets disease, " Rheumatology International, vol. 29, no. 2, pp. 173-178, 2008.
22. Y. Oishi, Y. Watanabe, S. Shinoda et al. , "The IL6 gene polymorphism -634C>G and IL17F gene polymorphism 7488T>C influence bone mineral density in young and elderly Japanese women, " Gene, vol. 504, no. 1, pp. 75-83, 2012.
23. E. Dander, A. Balduzzi, G. Zappa et al. , "Interleukin-17-producing t-helper cells as newpotential player mediating graftversus-host disease in patients undergoing allogeneic stem-cell transplantation, " Transplantation, vol. 88, no. 11, pp. 1261-1272, 2009.
24. A. Accardo Palumbo, G. I. Forte, D. Pileri et al. , "Analysis of IL-6, IL-10 and IL-17 genetic polymorphisms as risk factors for sepsis development in burned patients, " Burns, vol. 38, no. 2, pp. 208-213, 2012.
25. E. Crawley, R. Kay, J. Sillibiurne et al. , "Polymorphic haplotypes of the interleukin-10 5 flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis, " Arthritis and Rheumatology, vol. 42, no. 6, pp. 1101-1108, 1999.
26. O. Schroder, R. A. Laun, H. D. Roher et al. , "Heat shock protein 70 genotypes HSPA1B and HSPA1L influence cytokine levels and interfere with outcome after major injury, " Critical Care Medicine, vol. 31, no. 1, pp. 73-77, 2003.
27. L. Ma, H.-B. Xue, X.-H. Guan et al. , "Possible role of Th17 cells and IL-17 in the pathogenesis of atopic dermatitis in Northern China, " Journal of Dermatological Science, vol. 68, no. 1, pp. 66-68, 2012.
28. X. Chen, R. Das, R. Komorowski, J. van Snick, C. Uyttenhove, and W. R. Drobyski, "Interleukin 17 is not required for autoimmune-mediated pathologic damage during chronic graft-versus-host disease, " Biology of Blood and Marrow Transplantation, vol. 16, no. 1, pp. 123-128, 2010.